Stock Events

Aeterna Zentaris 

€4.79
0
+€0+0% Today

Statistics

Day High
4.79
Day Low
4.79
52W High
-
52W Low
-
Volume
0
Avg. Volume
-
Mkt Cap
-
P/E Ratio
-
Dividend Yield
-
Dividend
-

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ET80.F. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
AMGEN
AMGN
Mkt Cap177.72B
Amgen is a biotechnology company that competes in the development of treatments in areas similar to Aeterna Zentaris, including oncology and endocrinology.
Pfizer
PFE
Mkt Cap169.83B
Pfizer is a global pharmaceutical company with a broad product portfolio that includes drugs in areas competing with Aeterna Zentaris' focus, such as cancer and endocrine disorders.
Novo Nordisk
NVO
Mkt Cap445.94B
Novo Nordisk specializes in diabetes care and hormone replacement therapies, directly competing with Aeterna Zentaris' work in endocrinology.
Merck &
MRK
Mkt Cap318.55B
Merck is a global healthcare company that develops medicines and vaccines for many of the same diseases Aeterna Zentaris targets, including cancer.
Lilly(Eli) &
LLY
Mkt Cap814.94B
Eli Lilly is a company that focuses on pharmaceuticals in areas like endocrinology and oncology, making it a direct competitor to Aeterna Zentaris.
Abbvie
ABBV
Mkt Cap304.29B
AbbVie operates in the pharmaceutical industry, focusing on treatments for conditions that overlap with Aeterna Zentaris' interests, including hormonal therapies and cancer.
Gilead Sciences
GILD
Mkt Cap90.4B
Gilead Sciences is involved in the discovery, development, and commercialization of innovative therapeutics in areas of unmet medical need, competing with Aeterna Zentaris in the oncology and endocrinology sectors.
Bristol-Myers Squibb
BMY
Mkt Cap86.44B
Bristol Myers Squibb is a global biopharmaceutical company whose range of products in oncology and cardiovascular diseases competes with Aeterna Zentaris.
Sanofi
SNY
Mkt Cap128.21B
Sanofi is a diversified global healthcare leader that develops medications in several areas, including those that compete with Aeterna Zentaris' focus areas.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap19.04B
Teva Pharmaceutical Industries is a global leader in generic and specialty medicines, competing in the pharmaceutical space with a focus on generic versions of drugs that could compete with Aeterna Zentaris' products.

About

Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Its lead product is macimorelin, an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of adult growth hormone deficiency and childhood-onset growth hormone deficiency, as well as oncology indications. The company markets macimorelin under the Macrilen brand name. Aeterna Zentaris Inc. has a license agreement with University Wuerzburg to research, develop, manufacture, and sell a potential COVID-19 vaccine; development, manufacture, and commercialization of the treatment for neuromyelitis optica spectrum disorder; and to develop human 3D intestinal tissue models to study infection biology; and for pre-clinical development towards the potential treatment of Parkinson's disease. It also has a license agreement with Consilient Health Ltd., Novo Nordisk Novo Nordisk Health Care AG, and NK MEDITECH Ltd. for the development and commercialization of macimorelin in the United States and Canada, as well as The University of Sheffield, the United Kingdom for the research, development, manufacture, and commercialization of parathyroid hormone fusion polypeptides for the treatment of primary hypoparathyroidism. Aeterna Zentaris Inc. was incorporated in 1990 and is headquartered in Summerville, South Carolina.
Show more...
CEO
Klaus Paulini
Employees
12
Country
CA
ISIN
CA0079756007
WKN
000A403TN

Listings